成人窒息相关心脏骤停中旁观者人工呼吸与结局的关联
该回顾性队列研究利用全日本Utstein登记数据库(2005—2023年),纳入76,774例成人目击性窒息相关院外心脏骤停患者,比较旁观者单纯胸外按压CPR(CC-CPR,39,451例)、按压加通气CPR(CCV-CPR,8,182例)与无旁观者CPR(No CPR,29,141例)的结局。主要终点为1个月时良好神经功能状态,CC-CPR组与CCV-CPR组均为1.5%,No CPR组2.0%。经逆概率治疗加权调整后,No CPR组良好神经功能结局高于CC-CPR组(调整OR 1.20,95%CI 1.04—1.38),CCV-CPR组与CC-CPR组无显著差异(OR 1.01,95%CI 0.78—1.32)。作者认为,旁观者CPR类型本身可能不是恢复的主要决定因素,CPR类型、气道管理及其他院前因素的相对贡献尚待明确。
要点
- 在窒息相关院外心脏骤停中,旁观者CPR类型(单纯按压、按压加通气、无CPR)与1个月良好神经功能恢复均无显著改善关联。
- 经IPTW调整后,No CPR组良好神经功能结局高于CC-CPR组(调整OR 1.20,95%CI 1.04—1.38),CCV-CPR与CC-CPR无显著差异(OR 1.01,95%CI 0.78—1.32)。
- 1个月生存率:CC-CPR组8.3%、CCV-CPR组7.2%、No CPR组9.5%;No CPR组生存高于CC-CPR组(OR 1.20,95%CI 1.12—1.28),CCV-CPR组无显著差异。
- ROSC率三组分别为CC-CPR 19.9%、CCV-CPR 17.2%、No CPR 17.7%,组间无显著差异。
- 作者认为,旁观者CPR类型本身可能不是恢复的主要决定因素,CPR类型、气道管理及其他院前因素的相对贡献尚待明确。
适用人群与场景
- 成人目击性窒息相关院外心脏骤停患者,数据来自全日本Utstein登记数据库(2005—2023年)。
- 排除心源性病例及由急救人员(EMS personnel)处理的病例。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用全日本Utstein登记数据库(2005—2023年),共纳入76,774例成人目击性窒息相关院外心脏骤停患者。
- 分组:旁观者CPR分为单纯胸外按压CPR(CC-CPR,39,451例)、按压加通气CPR(CCV-CPR,8,182例)和无旁观者CPR(No CPR,29,141例),以CC-CPR为参照。
- 主要终点1个月良好神经功能状态:CC-CPR组1.5%、CCV-CPR组1.5%、No CPR组2.0%。经IPTW调整后,No CPR组高于CC-CPR组(调整OR 1.20,95%CI 1.04—1.38),CCV-CPR组与CC-CPR组无显著差异(OR 1.01,95%CI 0.78—1.32)。
- 次要终点1个月生存:CC-CPR组8.3%、CCV-CPR组7.2%、No CPR组9.5%;No CPR组高于CC-CPR组(OR 1.20,95%CI 1.12—1.28),CCV-CPR组无显著差异。
- 次要终点ROSC:CC-CPR组19.9%、CCV-CPR组17.2%、No CPR组17.7%,组间无显著差异。
- 预设亚组分析(年份、年龄、性别、EMS呼叫时间、旁观者类型、初始心律)及多重插补敏感性分析结果一致。
证据类型、等级与局限
- 证据类型:回顾性队列研究,使用全国性登记数据库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在窒息相关院外心脏骤停中,旁观者CPR类型本身可能不是恢复的主要决定因素,CPR类型、气道管理及其他院前因素的相对贡献尚待明确。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Out-of-hospital cardiac arrest (OHCA) is a public health concern. Whether conventional cardiopulmonary resuscitation (CPR) with rescue breathing may improve outcomes compared with compression-only or no CPR in suffocation-related OHCA is unclear.
METHODS: We conducted a retrospective cohort study using the All-Japan Utstein Registry (2005-2023). Adult patients with witnessed suffocation-related OHCA were included, excluding cardiac-origin cases and those treated by EMS personnel. Bystander CPR was categorized as chest compression-only CPR (CC-CPR), chest compression plus ventilation CPR (CCV-CPR), and no bystander CPR (No CPR), with CC-CPR as the reference. The primary outcome was favorable neurological status at one month; secondary outcomes were one-month survival and return of spontaneous circulation (ROSC). Inverse probability of treatment weighting (IPTW) was applied, and prespecified subgroup analyses were performed across year, age, sex, time of EMS call, bystander type, and initial rhythm.
RESULTS: Among 76,774 patients, 39,451 received CC-CPR, 8182 received CCV-CPR, and 29,141 received No CPR. Favorable neurological outcome occurred in 1.5%, 1.5%, and 2.0%; one-month survival in 8.3%, 7.2%, and 9.5%; and ROSC in 19.9%, 17.2%, and 17.7%, respectively. After IPTW adjustment, No CPR was associated with a higher likelihood of favorable neurological outcomes compared with CC-CPR (adjusted OR: 1.20, 95%CI: 1.04-1.38), whereas CCV-CPR showed no significant difference (OR: 1.01, 95%CI: 0.78-1.32). No CPR was also associated with higher one-month survival (OR: 1.20, 95%CI: 1.12-1.28), with no significant difference for CCV-CPR. No significant differences were observed for ROSC. Findings were consistent in subgroup and sensitivity analyses using multiple imputation.
CONCLUSIONS: In suffocation-related OHCA, the type of bystander CPR was not associated with improved neurological recovery. These findings suggest that the type of bystander CPR alone may not be the primary determinant of recovery, although the relative contributions of CPR type, airway management, and other prehospital factors remain to be clarified.
参考来源
- Okada A, Tominaga T, Iwakura M, et al. Association of rescue breathing with outcomes in adult suffocation-related cardiac arrest. Resuscitation. 2026. PMID: 42361892. doi:10.1016/j.resuscitation.2026.111189
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。